{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:27:37Z","timestamp":1793604457440,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T00:00:00Z","timestamp":1579305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.biopha.2020.109915","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T19:58:53Z","timestamp":1579895933000},"page":"109915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota\u2013bile acid\u2013farnesoid X receptor axis"],"prefix":"10.1016","volume":"124","author":[{"given":"Hongshan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfei","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajie","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2020.109915_bib0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-0035-1562942","article-title":"Diagnosis and assessment of NAFLD: definitions and histopathological classification","volume":"35","author":"Burt","year":"2015","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.biopha.2020.109915_bib0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2015.07.019","article-title":"Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease","volume":"14","author":"Mittal","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2020.109915_bib0015","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/gut.2009.199661","article-title":"Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications","volume":"59","author":"Stickel","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2020.109915_bib0020","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2020.109915_bib0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cld.2017.08.012","article-title":"Current treatment of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"22","author":"Hung","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.biopha.2020.109915_bib0030","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s40495-017-0106-1","article-title":"Rhodiola rosea L.: an herb with anti-stress, anti-aging, and immunostimulating properties for cancer chemoprevention","volume":"3","author":"Li","year":"2017","journal-title":"Curr. Pharmacol. Rep."},{"key":"10.1016\/j.biopha.2020.109915_bib0035","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jshs.2016.05.005","article-title":"Effects of Rhodiola rosea supplementation on mental performance, physical capacity, and oxidative stress biomarkers in healthy men","volume":"7","author":"Jowko","year":"2018","journal-title":"J. Sport Health Sci."},{"key":"10.1016\/j.biopha.2020.109915_bib0040","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.sjbs.2014.04.001","article-title":"Hepatoprotective effect of Rhodiola imbricata rhizome against paracetamol-induced liver toxicity in rats","volume":"21","author":"Senthilkumar","year":"2014","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.biopha.2020.109915_bib0045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3233\/JAD-151159","article-title":"Salidroside, a bioactive compound of Rhodiola rosea, ameliorates memory and emotional behavior in adult mice","volume":"52","author":"Palmeri","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2020.109915_bib0050","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s11596-019-2069-4","article-title":"Salidroside inhibits lipopolysaccharide-ethanol-induced activation of proinflammatory macrophages via notch signaling pathway","volume":"39","author":"Li","year":"2019","journal-title":"Curr. Med. Sci."},{"key":"10.1016\/j.biopha.2020.109915_bib0055","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejphar.2016.03.011","article-title":"Salidroside-regulated lipid metabolism with down-regulation of miR-370 in type 2 diabetic mice","volume":"779","author":"Zhang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2020.109915_bib0060","article-title":"Salidroside modulates insulin signaling in a rat model of nonalcoholic steatohepatitis","volume":"2017","author":"Li","year":"2017","journal-title":"Evid.-Based Complement. Alternat. Med."},{"key":"10.1016\/j.biopha.2020.109915_bib0065","doi-asserted-by":"crossref","DOI":"10.29219\/fnr.v63.1518","article-title":"Role of intestinal microecology in the regulation of energy metabolism by dietary polyphenols and their metabolites","volume":"63","author":"Lin","year":"2019","journal-title":"Food Nutr. Res."},{"key":"10.1016\/j.biopha.2020.109915_bib0070","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.canlet.2019.114425","article-title":"New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer","volume":"459","author":"Ezzaidi","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2020.109915_bib0075","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.phrs.2019.01.029","article-title":"Interactions between gut microbiota and non-alcoholic liver disease: the role of microbiota-derived metabolites","volume":"141","author":"Ding","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2020.109915_bib0080","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3803\/EnM.2016.31.4.500","article-title":"Bile acid nuclear receptor farnesoid X receptor: therapeutic target for nonalcoholic fatty liver disease","volume":"31","author":"Kim","year":"2016","journal-title":"Endocrinol. Metab. (Seoul)"},{"key":"10.1016\/j.biopha.2020.109915_bib0085","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.2147\/DDDT.S136792","article-title":"Salidroside pretreatment attenuates apoptosis and autophagy during hepatic ischemia-reperfusion injury by inhibiting the mitogen-activated protein kinase pathway in mice","volume":"11","author":"Feng","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.biopha.2020.109915_bib0090","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1053\/j.gastro.2017.01.014","article-title":"Farnesoid X receptor activation promotes hepatic amino acid catabolism and ammonium clearance in mice","volume":"152","author":"Massafra","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2020.109915_bib0095","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2020.109915_bib0100","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1248\/bpb.b16-00942","article-title":"Therapeutic effect of gypenosides on nonalcoholic steatohepatitis via regulating hepatic lipogenesis and fatty acid oxidation","volume":"40","author":"Li","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.biopha.2020.109915_bib0105","doi-asserted-by":"crossref","first-page":"D590","DOI":"10.1093\/nar\/gks1219","article-title":"The SILVA ribosomal RNA gene database project: improved data processing and web-based tools","volume":"41","author":"Quast","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2020.109915_bib0110","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nmeth.2604","article-title":"UPARSE: highly accurate OTU sequences from microbial amplicon reads","volume":"10","author":"Edgar","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.biopha.2020.109915_bib0115","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/ijc.30219","article-title":"Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis","volume":"139","author":"Xie","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2020.109915_bib0120","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/pr500920q","article-title":"Profiling of serum bile acids in a healthy Chinese population using UPLC-MS\/MS","volume":"14","author":"Xie","year":"2015","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.biopha.2020.109915_bib0125","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.1021\/acs.analchem.6b00573","article-title":"Key role for the 12-hydroxy group in the negative ion fragmentation of unconjugated C24 bile acids","volume":"88","author":"Lan","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.biopha.2020.109915_bib0130","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00029330-200705010-00011","article-title":"Effects of curcumin on peroxisome proliferator-activated receptor gamma expression and nuclear translocation\/redistribution in culture-activated rat hepatic stellate cells","volume":"120","author":"Cheng","year":"2007","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.biopha.2020.109915_bib0135","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3389\/fmicb.2019.00887","article-title":"Core gut bacteria analysis of healthy mice","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2020.109915_bib0140","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s00394-018-1844-5","article-title":"Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria","volume":"58","author":"Schwenger","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.biopha.2020.109915_bib0145","doi-asserted-by":"crossref","first-page":"159","DOI":"10.15403\/jgld.2014.1121.252.iwg","article-title":"Small intestinal bacterial overgrowth is associated with non-alcoholic fatty liver disease","volume":"25","author":"Fialho","year":"2016","journal-title":"J. Gastrointestin. Liver Dis."},{"key":"10.1016\/j.biopha.2020.109915_bib0150","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/jgh.13058","article-title":"Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease","volume":"31","author":"Kapil","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2020.109915_bib0155","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8597897","article-title":"Salidroside attenuates high-fat diet-induced nonalcoholic fatty liver disease via AMPK-dependent TXNIP\/NLRP3 pathway","volume":"2018","author":"Zheng","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2020.109915_bib0160","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.fct.2019.01.007","article-title":"Ameliorative effect of salidroside from Rhodiola Rosea L. on the gut microbiota subject to furan-induced liver injury in a mouse model","volume":"125","author":"Yuan","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2020.109915_bib0165","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40360-016-0059-8","article-title":"Salidroside alleviates oxidative stress in the liver with non- alcoholic steatohepatitis in rats","volume":"17","author":"Yang","year":"2016","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2020.109915_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2018.12.018","article-title":"Developments in bile salt based therapies: a critical overview","volume":"161","author":"Donkers","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2020.109915_bib0175","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pharmthera.2018.04.005","article-title":"Bile acid regulation: a novel therapeutic strategy in non-alcoholic fatty liver disease","volume":"190","author":"Yu","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2020.109915_bib0180","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.bbalip.2019.05.016","article-title":"Turnover of bile acids in liver, serum and caecal content by high-fat diet feeding affects hepatic steatosis in rats","volume":"1864","author":"Tang","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.biopha.2020.109915_bib0185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.livres.2017.05.001","article-title":"Bile acid metabolism and signaling in liver disease and therapy","volume":"1","author":"Chiang","year":"2017","journal-title":"Liver Res."},{"key":"10.1016\/j.biopha.2020.109915_bib0190","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.molmed.2015.09.001","article-title":"Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders","volume":"21","author":"Fiorucci","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biopha.2020.109915_bib0195","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/acs.molpharmaceut.6b01155","article-title":"Impact of gut microbiota-mediated bile acid metabolism on the solubilization capacity of bile salt micelles and drug solubility","volume":"14","author":"Enright","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2020.109915_bib0200","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2020.109915_bib0205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00253-016-8006-6","article-title":"Interaction of gut microbiota with bile acid metabolism and its influence on disease states","volume":"101","author":"Staley","year":"2017","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.biopha.2020.109915_bib0210","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Chavez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2020.109915_bib0215","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2020.109915_bib0220","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2020.109915_bib0225","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1053\/j.gastro.2016.08.057","article-title":"An intestinal microbiota-farnesoid X receptor axis modulates metabolic disease","volume":"151","author":"Gonzalez","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2020.109915_bib0230","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2020.109915_bib0235","doi-asserted-by":"crossref","first-page":"33052","DOI":"10.1038\/srep33052","article-title":"Curcumin protects ANIT-induced cholestasis through signaling pathway of FXR-regulated bile acid and inflammation","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2020.109915_bib0240","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2020.109915_bib0245","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1002\/jcb.27635","article-title":"Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics","volume":"120","author":"Chen","year":"2019","journal-title":"J. Cell. Biochem."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220301050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220301050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:52:55Z","timestamp":1760097175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220301050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":49,"alternative-id":["S0753332220301050"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.109915","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota\u2013bile acid\u2013farnesoid X receptor axis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.109915","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109915"}}